跳至主要内容
临床试验/EUCTR2010-023947-14-ES
EUCTR2010-023947-14-ES进行中(未招募)1 期

Prospective, Randomized and Comparative Study to evaluate the efficacy of two vaccines against Hepatitis B virus in inflammatory bowel disease patients - COMVI-B Proyect

Hospital Universitario La Princesa0 个研究点开始时间: 2011年9月15日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1) Patients diagnosed of IBD with negative HBV serology.
  • 2) Men & women commited to abstinence of sexual relations or to use, al least, an effective birth control method (condom, diaphragm, IUD)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 118
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 118

排除标准

  • 1- Age below 18 years old.
  • 2- Advanced Chronic Disease or any other disease that prevent from attending controls and follow-up.
  • 3- Allergy to any of the vaccine components.
  • 4- Previous vaccination to the HBV.
  • 5- Women willing to get pregnant.
  • 6- Pregnancy or breastfeeding.
  • 7- alcohol abuse.
  • 8- Positive serology to HBV.
  • 9- People with immune disorders caused by other causes than treatments administered to control IBD.
  • 10- People with chronic antibiotic treatment.
  • 11- Lack of consent for participating in the study.

研究者

发起方
Hospital Universitario La Princesa

相似试验